Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
The chart shows the growth of an initial investment of $10,000 in GENPACT LIMITED, comparing it to the performance of the S&P 500 index. All prices have been adjusted for splits and dividends.
Returns By Period
GENPACT LIMITED (G) has returned -19.31% so far this year and -17.65% over the past 12 months. Looking at the last ten years, G has achieved an annualized return of 3.13%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
G
1M-7.18%
6M-8.35%
YTD-19.31%
1Y-17.65%
5Y-3.15%
10Y3.13%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of GENPACT LIMITED (G) with color gradation from worst to best to easily spot seasonal factors.
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
-5.71%
-10.05%
-4.14%
1.32%
2025
12.76%
11.04%
-5.46%
0.20%
-13.90%
2.64%
-0.02%
5.22%
-6.95%
-8.56%
15.43%
6.25%
2024
3.73%
-5.40%
-3.09%
-6.85%
7.93%
-2.45%
7.70%
13.15%
0.23%
-2.65%
20.87%
-7.01%
2023
1.26%
1.25%
-2.88%
-3.34%
-17.11%
1.60%
-3.99%
3.67%
-3.60%
-7.22%
1.52%
2.60%
2022
-6.77%
-15.78%
4.42%
-7.98%
10.43%
-4.89%
13.34%
-1.47%
-6.37%
9.73%
-5.45%
0.26%
2021
-7.38%
4.79%
4.57%
10.13%
-3.97%
-1.24%
9.45%
3.76%
-8.48%
3.03%
-2.50%
8.28%
2020
4.29%
-13.67%
-24.57%
22.83%
7.03%
1.47%
9.13%
5.45%
-7.26%
-11.98%
17.01%
1.05%
2019
11.85%
11.29%
5.17%
2.69%
-0.66%
5.22%
3.52%
3.02%
-5.02%
0.72%
3.33%
3.76%
2018
6.26%
-7.30%
2.04%
-0.34%
-5.57%
-4.14%
5.38%
0.43%
-10.66%
10.51%
-12.37%
2017
0.73%
-2.26%
1.52%
-1.29%
11.60%
1.50%
4.13%
-2.40%
0.56%
5.91%
5.74%
-1.37%
2016
2.95%
1.11%
-4.45%
-0.22%
-11.75%
1.23%
-4.25%
4.13%
1.80%
Performance Indicators
The charts below present risk-adjusted performance metrics for GENPACT LIMITED (G) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of G compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current GENPACT LIMITED volatility is 1.64%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses. Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Liabilities And Equity (USD)
5.84B
4.81B
4.59B
4.98B
4.87B
4.45B
3.53B
3.45B
2.89B
2.79B
2.74B
2.69B
2.61B
2.40B
Temporary Equity (USD)
-
-
-
-
-
-
-
4.75M
4.52M
-
-
-
-
-
Equity Attributable To Parent (USD)
2.55B
2.25B
1.83B
1.90B
1.83B
1.69B
1.40B
1.42B
1.29B
1.30B
1.29B
1.32B
1.17B
1.43B
Equity Attributable To Noncontrolling Interest (USD)
Nalanda India Equity Fund increased its Genpact holding by 1,015,556 shares worth approximately $43.92 million, signaling a bullish outlook. Despite a 27.3% year-over-year stock decline driven by AI obsolescence concerns, Genpact delivered 7% revenue growth in 2025 and expects similar growth in 2026 as it helps clients adopt AI. The stock's P/E ratio of 12 is at a one-year low, presenting a potentially attractive entry point.
The Motley Fool•Robert Izquierdo
AI Insight
Despite recent stock decline, the company shows strong fundamentals with 7% YoY revenue growth, expectations for continued 7% growth in 2026, and a compelling valuation (P/E of 12). The institutional investment by Nalanda and the company's successful positioning in AI adoption support a positive outlook.
The North America Business Process Outsourcing market is projected to grow from $112.96 billion in 2024 to $211.73 billion by 2033, driven by technological advancements, cost-saving needs, and digital transformation across industries.
GlobeNewswire Inc.•Researchandmarkets.Com
AI Insight
Listed as a market participant without specific performance details
Genpact Limited, a global advanced technology services and solutions company, announced that its board of directors has declared a cash dividend of $0.17 per common share for the second quarter of 2025.
Benzinga•Prnewswire
AI Insight
The company has declared a quarterly cash dividend, which is a positive sign for shareholders and indicates the company's financial stability and ability to return capital to investors.
The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.
GlobeNewswire Inc.•Researchandmarkets.Com
AI Insight
The article mentions Genpact Ltd. as one of the major companies in the regulatory affairs outsourcing market, but does not provide any specific information about the company's performance or outlook.
The Industrial Services Market is projected to grow from $35.47 billion in 2023 to $65.76 billion by 2032, driven by the increasing adoption of Industry 4.0 technologies like IoT, AI, and advanced analytics in industrial systems.
GlobeNewswire Inc.•Sns Insider
AI Insight
Genpact provides industrial analytics solutions and digital process transformation services, which are crucial for helping industrial companies leverage data and technology to optimize their operations.
The European pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.2% from 2023 to 2031, driven by the rise in adverse drug reactions, globalization of pharmacovigilance, and the integration of software with AI, ML, and NLP. Cloud-based platforms are a key market trend, enabling real-time monitoring and faster response to safety signals.
GlobeNewswire Inc.•Researchandmarkets.Com
AI Insight
The article lists Genpact as one of the key players in the European pharmacovigilance and drug safety software market, but does not provide any additional details about the company's performance or market position.
The global pharmaceutical regulatory affairs market is expected to reach $14.34 billion by 2030, driven by changes in regulatory landscape, growth in emerging areas, and entry of companies into the global market.
GlobeNewswire Inc.•
AI Insight
The article lists Genpact as one of the key players in the pharmaceutical regulatory affairs market, but does not provide any additional information about the company's role or performance.
Genpact Limited announced that its board of directors has declared a cash dividend of $0.1525 per common share for the fourth quarter of 2024, payable on December 23, 2024 to shareholders of record as of December 9, 2024.
Benzinga•Prnewswire
AI Insight
The company is paying a quarterly cash dividend to its shareholders, which is generally seen as a positive sign for the company's financial health and confidence in its future performance.
Accenture and Unilever have collaborated to leverage generative AI to enhance efficiency and operational agility across Unilever's digital infrastructure. The partnership aims to identify areas where AI can generate the most significant transformative impact, ultimately yielding higher returns on investment.
Benzinga•Zacks
AI Insight
Genpact is mentioned as another better-ranked stock from the broader Zacks Business Services sector, but it is not the main focus of the article.